Results 221 to 230 of about 7,236 (237)
Some of the next articles are maybe not open access.
The Amplatzer®Septal Occluder, a transcatheter device for atrial septal defect closure
Expert Review of Medical Devices, 2008Transcatheter device closure of secundum atrial septal defect (ASD) has been widely accepted and is becoming the standard treatment of this malformation. Among the devices used for transcatheter closure, the Amplatzer Septal Occluder is the first device to receive full approval from the US FDA for clinical use in patients with secundum ASD. It is safe,
Yun-Ching, Fu, Ziyad M, Hijazi
openaire +2 more sources
Closure of Chronic Bronchopleural Fistula Using Atrial Septal Occluder Device
Journal of Bronchology & Interventional Pulmonology, 2014Chronic persistent bronchopleural fistulae (BPF) are challenging management problems. The management of BPF includes various surgical and medical procedures and of great value is the use of bronchoscopy and different devices. In high-risk surgical patients, bronchoscopic procedures serve as a temporary bridge until the patient's clinical condition ...
Vikas, Marwah +3 more
openaire +2 more sources
Percutaneous rescue of left ventricular embolized amplatzer septal occluder device
Catheterization and Cardiovascular Interventions, 2008AbstractTranscatheter atrial septal defect (ASD) closure has proven to be safe and effective, and it is rapidly becoming the standard treatment for secundum‐type ASDs. However, device embolization occurs in about 0.55% of cases, regardless of ASD and device size and/or physician's expertise. Percutaneous retrieval of the embolized device is possible in
BALBI, MANRICO +2 more
openaire +3 more sources
Scandinavian Cardiovascular Journal, 2000
There is an 80-90% mortality rate within the first 2 months of the occurrence of a post-infarction ventricular septal defect (VSD) with medical treatment alone. The muscular VSD presents a technical problem for the surgeon. Surgical treatment was unsuccessful in two patients.
E, Pesonen +9 more
openaire +2 more sources
There is an 80-90% mortality rate within the first 2 months of the occurrence of a post-infarction ventricular septal defect (VSD) with medical treatment alone. The muscular VSD presents a technical problem for the surgeon. Surgical treatment was unsuccessful in two patients.
E, Pesonen +9 more
openaire +2 more sources
The American Journal of the Medical Sciences, 2016
Transcatheter closure has been a recognised treatment strategy for multiple atrial septal defects (mASDs). This study aimed to examine the feasibility, effectiveness, and safety of transcatheter closure of mASDs using dual Amplatzer septal occluder (ASO) devices.We retrospectively reviewed 34 patients who underwent transcatheter closure of mASDs using ...
Yankun, Yang +9 more
openaire +2 more sources
Transcatheter closure has been a recognised treatment strategy for multiple atrial septal defects (mASDs). This study aimed to examine the feasibility, effectiveness, and safety of transcatheter closure of mASDs using dual Amplatzer septal occluder (ASO) devices.We retrospectively reviewed 34 patients who underwent transcatheter closure of mASDs using ...
Yankun, Yang +9 more
openaire +2 more sources
Late Bacterial Endocarditis of an Amplatzer Atrial Septal Defect Occluder Device
The American Journal of Cardiology, 2010A 66-year-old man with a large secundum atrial septal defect (ASD) that had been repaired percutaneously 30 months previously with an Amplatzer ASD occluder (ASO) presented with fevers and Staphylococcus aureus bacteremia. Transesophageal echocardiography revealed a 1.5 x 1.5 cm mobile mass on the left atrial side of his ASO consistent with a ...
Firas, Zahr +3 more
openaire +2 more sources
Initial human experience with the Amplatzer perimembranous ventricular septal occluder device
Catheterization and Cardiovascular Interventions, 2003AbstractTranscatheter closure of perimembranous ventricular septal defects with coils or devices designed to close other lesions may be complicated by embolization or aortic insufficiency. A new asymmetric Amplatzer perimembranous ventricular septal occluder and delivery system was specifically designed for perimembranous defects. This report describes
John L, Bass +10 more
openaire +2 more sources
Erosion of an Amplatzer Septal Occluder Device Into the Aortic Root
The Annals of Thoracic Surgery, 2011Atrial septal defects can be closed surgically or percutaneously. We report a patient who underwent percutaneous closure of an atrial septal defect with an Amplatzer septal occluder device (AGA Medical Corp, Golden Valley, MN). The patient presented 4 months later with congestive heart failure secondary to an erosion of the Amplatzer septal occluder ...
Abdallah, Kamouh +3 more
openaire +2 more sources
Surgical Treatment of Atrial Septal Defect by Occluder Device
2018Interatrial communication (ASD) is an acyanogenic congenital heart disease characterized by left-right shunt, with a prevalence of 5–10% among all congenital heart defects, rarely diagnosed in infancy and predominant in females. Clinical manifestations usually begin between the third and fourth decades of life and consist of dyspnea, fatigue, and ...
Laura Gomes Flores +4 more
openaire +1 more source
Extracardial migration of an atrial septal defect occluder device.
The Journal of invasive cardiology, 2015Several complications have been reported regarding the percutaneous closure of secondary atrial septal defects such as erosion, thromboembolic events, arrhythmias, and endocarditis. In this report, we describe the case of a 75-year-old woman who underwent percutaneous closure of a secondary atrial septal defect with a 12 mm Amplatzer septal occluder ...
Ioannis, Karampinis +2 more
openaire +1 more source